OneSource Specialty Pharma Limited (ONESOURCE) Financial Statements

0 Followers

OneSource Specialty Pharma Limited Financial Overview

OneSource Specialty Pharma Limited's market cap is currently ₹214.11B. The company's EPS TTM is ₹9.53; its P/E ratio is 920.22; OneSource Specialty Pharma Limited is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 25
Income Statement
Total Revenue	₹ 14.45B	₹ 14.22B
Gross Profit	₹ 10.10B	₹ 4.56B
Operating Income	₹ 1.90B	₹ 251.29M
EBITDA	₹ 3.61B	₹ 3.04B
Net Income	₹ -2.10M	₹ -738.03M
Balance Sheet
Cash & Short-Term Investments	₹ 36.21M	₹ 1.03B
Total Assets	₹ 75.50B	₹ 82.10B
Total Debt	₹ 9.42B	₹ 15.04B
Net Debt	₹ 7.86B	₹ 14.06B
Total Liabilities	₹ 209.75M	₹ 23.79B
Stockholders' Equity	₹ 58.81B	₹ 58.31B
Cash Flow
Free Cash Flow	₹ -1.96B	₹ -6.80B
Operating Cash Flow	₹ -24.69M	₹ -1.11B
Investing Cash Flow	₹ -25.05M	₹ -4.95B
Financing Cash Flow	₹ 66.47M	₹ 4.79B

Currency in INR

OneSource Specialty Pharma Limited Earnings and Revenue History

Income Statement >

OneSource Specialty Pharma Limited Debt to Assets

Balance Sheet >

OneSource Specialty Pharma Limited Cash Flow

Cash Flow >

OneSource Specialty Pharma Limited Forecast EPS vs Actual EPS

Earnings >